Skip to main content
Premium Trial:

Request an Annual Quote

Eureka Genomics, James Hutton Institute Co-develop Assay to Genotype Barley

NEW YORK (GenomeWeb News) – Eureka Genomics said today it is developing a custom assay for genotyping barley in collaboration with Scotland's James Hutton Institute.

The assay, which will be priced at $15 per sample, will allow for the identification of more than 400 SNPs in a single test, giving researchers the option of a low-cost method for identifying and optimizing traits such as yield, quantity, and environmental resilience for commercial crop production, Hercules, Calif.-based Eureka said. It plans to launch the assay next month in Europe and the US.

The assay will be developed based on next-generation sequencing and can be broadly applied to detect SNPS, copy number variations, presence/absence and methylation. It is compatible with DNA and RNA from almost any organism even when information about the genome is missing, Eureka said

"The collaboration has resulted in a very cost-effective, medium-throughput approach to single nucleotide polymorphism genotyping, a fundamental technology in both genetic studies and contemporary crop improvement programs worldwide," Robbie Waugh, head of genetics at the James Hutton Institute, said in a statement.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.